Anti-SRSF1/SF2 Antibody (2D188) is a Rabbit antibody targeting SRSF1/SF2. Anti-SRSF1/SF2 Antibody (2D188) can be used in WB, IHC-P, IHC-Fr, ICC/IF, IF, FCM.

IgG

2D188

Human (predicted:Mouse,Rat)

25 ug total protein per lane of various lysates (see on figure) probed with SRSF1/SF2 monoclonal antibody, unconjugated (TMAB-13164) at 1: 1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r. T. for 60 min.

WB: 1:500-2000; IHC-P: 1:50-200; IHC-Fr: 1:50-200; ICC/IF: 1:50-200; IF: 1:50-200; FCM: 1:50-100

Monoclonal

A synthesized peptide: human SRSF1

Human

SRSF1

Serine/arginine-rich splicing factor 1

Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CGAGGCG-3' motif in vitro. Three copies of the octamer constitute a powerful splicing enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can specifically activate ASE-dependent splicing. Isoform ASF-2 and isoform ASF-3 act as splicing repressors.